291
Views
5
CrossRef citations to date
0
Altmetric
Review

Pharmacological management of adult patients with acute respiratory distress syndrome

, , ORCID Icon & ORCID Icon
Pages 2169-2183 | Received 20 Apr 2020, Accepted 23 Jul 2020, Published online: 12 Aug 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Maria Gabriella Matera, Francesco Imperatore, Rosa Annibale & Mario Cazzola. (2022) Advances in the Pharmacological Management of Pediatric Acute Respiratory Distress Syndrome. Expert Opinion on Pharmacotherapy 23:3, pages 349-360.
Read now
Maria Gabriella Matera, Paola Rogliani, Josuel Ora, Luigino Calzetta & Mario Cazzola. A comprehensive overview of investigational elastase inhibitors for the treatment of acute respiratory distress syndrome. Expert Opinion on Investigational Drugs 0:0.
Read now

Articles from other publishers (3)

Shuomiao Yin, Meizhu Ding, Long Fan, Xuhua Yu, Ziyao Liang, Lei Wu, Zhiling Gao, Lin Lin & Yuanbin Chen. (2021) Inhibition of Inflammation and Regulation of AQPs/ENaCs/Na+-K+-ATPase Mediated Alveolar Fluid Transport by Total Flavonoids Extracted From Nervilia fordii in Lipopolysaccharide-induced Acute Lung Injury. Frontiers in Pharmacology 12.
Crossref
Grazia Mazzeo, Luigi Aronne, Domenica Francesca Mariniello, Valentino Allocca, Maria Ilaria Palma, Francesco Saverio Cerqua, Carlo Iadevaia, Adriano Costigliola, Roberto Parrella, Andrea Bianco & Vanvitelli/Monaldi COVID Group. (2021) Which impact for proton pump inhibitors in SARS-COV-2 pneumonia. Monaldi Archives for Chest Disease.
Crossref
Filippo Scialo, Maria Vitale, Aurora Daniele, Ersilia Nigro, Fabio Perrotta, Monica Gelzo, Carlo Iadevaia, Francesco Saverio Cerqua, Adriano Costigliola, Valentino Allocca, Felice Amato, Lucio Pastore, Giuseppe Castaldo & Andrea Bianco. (2021) SARS-CoV-2: One Year in the Pandemic. What Have We Learned, the New Vaccine Era and the Threat of SARS-CoV-2 Variants. Biomedicines 9:6, pages 611.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.